Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Conditions
Acute Coronary Syndrome
Interventions
DRUG

loading with Ticagrelor

Patients allocated in the two study arms will receive the same anti platelet treatment, except for the administration of the loading dose, which will be only administered to patients allocated in Group 2

DRUG

no loading with Ticagrelor

"Patients allocated in the two study arms will receive the same anti platelet treatment, except for the administration of the loading dose, which will be only administered to patients allocated in Group 2.~In other words, patients randomized to this group (group 1) will not receive a loading dose of ticagrelor during the passage from clopidogrel to ticagrelor."

Trial Locations (1)

88100

Magna Graecia University, Catanzaro

All Listed Sponsors
lead

University Magna Graecia

OTHER

NCT01795820 - Platelet Aggregation During the Shift From Clopidogrel to Ticagrelor | Biotech Hunter | Biotech Hunter